Terug
Dagbereik
€ 6,91
€ 7,24
52-Weeksbereik
€ 6,11
€ 11,78
Volume
115.642
50D / 200D Gem.
€ 7,92
/
€ 7,75
Vorige Slotkoers
€ 7,04
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 125,5 | 0,3 |
| P/B | 6,0 | 2,9 |
| ROE % | 5,9 | 3,7 |
| Net Margin % | 4,3 | 3,8 |
| Rev Growth 5Y % | 99,7 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 16,00
+130.5%
Forward WPA
-€ 0,32
Omzet Sch.
140 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,25
€ 0,21 – € 0,31
|
310 M | 1 |
| FY2029 |
€ 0,11
€ 0,09 – € 0,14
|
270 M | 1 |
| FY2028 |
€ 1,71
€ 1,42 – € 2,12
|
440 M | 1 |
Belangrijkste Punten
Revenue grew 99,65% annually over 5 years — strong growth
Earnings declined -58,40% over the past year
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -180.000,0
P/E of 125,48 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 89,41%
Groei
Revenue Growth (5Y)
99,65%
Revenue (1Y)10,24%
Earnings (1Y)-58,40%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
5,94%
ROIC8,05%
Net Margin4,31%
Op. Margin9,85%
Veiligheid
Debt / Equity
0,01
Current Ratio5,60
Interest Coverage0,00
Waardering
P/E Ratio
125,48
P/B Ratio5,95
EV/EBITDA51,77
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,24% | Revenue Growth (3Y) | 1,37% |
| Earnings Growth (1Y) | -58,40% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 99,65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 116,59M | Net Income (TTM) | 5,03M |
| ROE | 5,94% | ROA | 3,03% |
| Gross Margin | 95,35% | Operating Margin | 9,85% |
| Net Margin | 4,31% | Free Cash Flow (TTM) | -180.000,0 |
| ROIC | 8,05% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,60 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 125,48 | P/B Ratio | 5,95 |
| P/S Ratio | 5,41 | PEG Ratio | -2,10 |
| EV/EBITDA | 51,77 | Dividend Yield | 0,00% |
| Market Cap | 630,78M | Enterprise Value | 594,65M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 116,59M | 105,76M | 113,45M | 102,29M | 7,34M |
| Net Income | 5,03M | 12,09M | -92,93M | 2,30M | -87,93M |
| EPS (Diluted) | 0,02 | 0,05 | -1,41 | 0,03 | -2,87 |
| Gross Profit | 111,17M | 101,87M | 108,81M | 97,50M | -332.000,0 |
| Operating Income | 11,49M | 16,16M | -67,23M | 9,20M | -83,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 166,13M | 125,41M | 116,54M | 84,75M | 55,66M |
| Total Liabilities | 23,85M | 27,00M | 102,59M | 12,54M | 14,57M |
| Shareholders' Equity | 106,03M | 63,32M | -15,83M | 42,52M | 41,09M |
| Total Debt | 939.000,0 | 1,60M | 409.000,0 | 613.000,0 | 2,39M |
| Cash & Equivalents | 37,07M | 11,81M | 33,51M | 25,18M | 44,35M |
| Current Assets | 102,37M | 64,79M | 57,22M | 49,65M | 51,48M |
| Current Liabilities | 18,29M | 19,52M | 20,05M | 12,24M | 14,17M |